EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Semaglutide in Adults with Type 1 Diabetes and Obesity

Viral N Shah, Halis K Akturk, Davida Kruger, Andrew Ahmann, Anuj Bhargava, Giorgos Bakoyannis, Laura Pyle, Janet K Snell-Bergeon

NEJM Evidence · 22.07.2025 · 4 (8)

DOI: 10.1056/evidoa2500173 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 22.07.2025. Verfasst von Viral N Shah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Glucagon-Like Peptides, Hypoglycemic Agents, Obesity. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Glucagon-Like PeptidesHypoglycemic AgentsObesityHumansFemaleAdultMaleDouble-Blind MethodMiddle AgedBlood GlucoseGlycated HemoglobinTreatment OutcomeWeight LossBody Mass IndexGlucagon-Like Peptide 1Semaglutide

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsBlood GlucoseGlycated HemoglobinGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis.
  • Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora.
  • Division of Endocrinology, Diabetes, and Bone and Mineral Disease, Henry Ford Health, Detroit.
  • Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health and Science University, Portland.
  • Iowa Diabetes Research, Des Moines.
  • Department of Biostatistics and Health Data Science, Fairbank School of Public Health, Indiana University School of Medicine, Indianapolis.

Zitieren

APA

Shah, V. N., Akturk, H. K., Kruger, D., Ahmann, A., Bhargava, A., Bakoyannis, G., Pyle, L., & Snell-Bergeon, J. K. (2025). Semaglutide in Adults with Type 1 Diabetes and Obesity. NEJM Evidence, 4(8). https://doi.org/10.1056/evidoa2500173

Vancouver

Shah VN, Akturk HK, Kruger D, Ahmann A, Bhargava A, Bakoyannis G, et al. Semaglutide in Adults with Type 1 Diabetes and Obesity. NEJM Evidence. 2025;4(8). doi:10.1056/evidoa2500173

BibTeX
@article{Shah2025,
  author = {Shah, Viral N and Akturk, Halis K and Kruger, Davida and Ahmann, Andrew and Bhargava, Anuj and Bakoyannis, Giorgos and Pyle, Laura and Snell-Bergeon, Janet K},
  title = {Semaglutide in Adults with Type 1 Diabetes and Obesity},
  journal = {NEJM Evidence},
  year = {2025},
  volume = {4},
  number = {8},
  doi = {10.1056/evidoa2500173}
}
Kostenlos starten →